Ocugen, Inc. — Director's Dealing 2024

Jul 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2024-06-28

Reporting Person: Castillo Kirsten (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-28	Option (Right to Buy)	$1.55	A	66929	Acquired	2034-06-28	Common Stock (66929)	Direct

Footnotes

F1: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.